|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| C07D 487/04 | |||
| C07D 519/00 | |||
| A61K 31/5517 | |||
| A61P 35/00 |
| (11) | Number of the document | 3053600 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16150802.3 |
| Date of filing the European patent application | 2012-02-15 | |
| (97) | Date of publication of the European application | 2016-08-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161443062 P | 2011-02-15 | US | |
| 201161443092 P | 2011-02-15 | US | |
| 201161483499 P | 2011-05-06 | US |
| (72) |
LI, Wei, US
MILLER, Michael Louis, US
FISHKIN, Nathan Elliott, US
CHARI, Ravi V.J., US
|
| (73) |
ImmunoGen, Inc.,
830 Winter Street, Waltham, MA 02451,
US
|
| (54) | CYTOTOXIC BENZODIAZEPINE DERIVATIVES |
| CYTOTOXIC BENZODIAZEPINE DERIVATIVES |